Clinical Significance of Free-to-Total Prostate-Specific Antigen (PSA) Ratio in Advanced Prostate Cancer Patients with PSA Less than 0.1 ng/ml after Hormone Treatment

PURPOSE: We analyzed the pattern of change in the free-to-total prostate-specific antigen (f/t PSA) ratio and the progression to castration-resistant prostate cancer (CRPC) in patients with advanced prostate cancer who received hormone treatment and whose PSA nadir was below 0.1 ng/ml. MATERIALS AND...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Dae Il, Song, Jae Mann, Chung, Hyun Chul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Urological Association 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3312061/
https://www.ncbi.nlm.nih.gov/pubmed/22468208
http://dx.doi.org/10.4111/kju.2012.53.3.149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3312061/
https://www.ncbi.nlm.nih.gov/pubmed/22468208
http://dx.doi.org/10.4111/kju.2012.53.3.149

Ejemplares similares